Abstract:The NMDA receptor and the brain-derived neurotrophic factor (BDNF) are involved in central sensitization and synaptic plasticity in the spinal cord. To determine whether the spinal cord BDNF contributes to the development and maintenance of neuropathic pain by activation of the dorsal horn NR2B-containing NMDA (NMDA-2B) receptors, this study was designed to investigate if alterations in BDNF and its TrkB receptor in the spinal dorsal horn would parallel the timeline of the development of neuropathic pain in lumbar 5 (L5) spinal nerve ligated (SNL) rats. The enzyme-linked immunosorbent assay (ELISA) showed that the BDNF concentration significantly increased during 24 h post-surgery, and the maximal enhancement lasted for 48 h. It declined as time progressed and returned to the level of pre-operation at 28 days after SNL. In parallel with the alteration of BDNF concentration in the spinal dorsal horn, the 50% paw withdrawal threshold (PWT) of the ipsilateral hind paw in SNL rats also showed a significant decrease during 24–48 h after SNL as compared with those in sham-operated rats. The correlation analysis revealed that the BDNF concentration had a negative correlation with 50% PWT in early stage (0–48 h) (r=-0.974, p=0.001), but not late stage (3–28 days) (r=0.3395, p=0.6605), after SNL. Similarly, the immunohistochemical staining revealed that a significant up-regulation of BDNF expression in the spinal dorsal horn appeared as early as 12 h post-operation in SNL rats, peaked at 24–48 h, declined at 3 days and disappeared at 14 days after SNL. In contrast, an increase in NMDA-2B receptors expression in the spinal dorsal horn was delayed to 48 h after SNL. The increase reached peak at 3 days, lasted for 14 days, and returned to the control level of pre-operation at 28 days after SNL. The maximal enhancement of BDNF expression occurred in early stage (24–48 h) after nerve injury, while the peak of NMDA-2B receptors expression appeared in late stage (3–14 days) post-nerve ligation. As compared with the dynamic changes of 50% PWT in the timeline after nerve injury, the maximal enhancement of BDNF expression closely paralleled the maximal decline in the slope of 50% PWT, while the peak of NMDA-2B receptors expression corresponded with the plateau of the decreased 50% PWT. Therefore, the increased BDNF in the spinal dorsal horn was likely to be associated with the initiation of neuropathic pain in early stage (0–48 h), while the activation of NMDA-2B receptors was involved in the maintenance of persistent pain states in late stage (2–14 days) after nerve injury. Moreover, the present study also demonstrated that the BDNF/TrkB-mediated signaling pathway within the spinal cord might be involved in the induction of neuropathic pain in early stage after nerve injury, and the selective NMDA-2B receptors antagonist (Ro 25-6981) almost completely blocked the BDNF-induced mechanical allodynia in all of the tested rats. These data suggested that the BDNF/TrkB-mediated signaling pathway in the spinal cord was involved in the development of nerve injury-induced neuropathic pain through the activation of dorsal horn NMDA-2B receptors.

Effects of BDNF on Activation of Spinal Dorsal Horn Astrocytes in Rats with Spinal Nerve Ligation

UPREGULATION OF THE BRAIN-DERIVED NEUROTROPHIC FACTOR IN THE SPINAL DORSAL HORN OF NEUROPATHIC RATS INDUCED BY SPINAL NERVE LIGATION

Effect of sciatic nerve pulsed radiofrequency glial activation levels in spinal dorsal horn in chronic constriction injury rat models and its analgesia effect

Effects of Ghrelin on Pgsk-3Β and Β-Catenin Expression when Protects Against Neuropathic Pain Behavior in Rats Challenged with Chronic Constriction Injury

Effects of Glial Cell Line-Derived Neurotrophic Factor Intrathecal Injection on Spinal Dorsal Horn Glial Fibrillary Acidic Protein Expression in a Rat Model of Neuropathic Pain

Contribution of BDNF/TrkB Pathway to Development of Neuropathic Pain by Activation of Astrocytes in Rats

Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation.

Effect of Glial Cell Line-Derived Neurotrophic Factor on Fos Protein Expression in the Spinal Dorsal Horn of Neuropathic Pain Rat Model

The effect of intrathecal administration of glial activation inhibitors on dorsal horn BDNF overexpression and hind paw mechanical allodynia in spinal nerve ligated rats

Effects of Intrathecal Injection of Exogenous BDNF-activated Astrocytes on Pain Sensation of Normal Rats

BDNF Contributes to Spinal Long-Term Potentiation and Mechanical Hypersensitivity Via Fyn-Mediated Phosphorylation of NMDA Receptor GluN2B Subunit at Tyrosine 1472 in Rats Following Spinal Nerve Ligation

Threshold of rats with partial sciatic nerve ligation as well as SCN9a gene and glial cell expression

ANALGESIC EFFECT OF INTRATHECAL ANTISENSE OLIGODEOXYNUCLEOTIDE OF TLR3 ON RATS FOLLOWING SPINAL NERVE LIGATION

EFFECT OF GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR ON RAT NEUROPATHIC PAIN

EFFECTS OF GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR ON THE PRODUCT OF NO AND THE ACTIVITY OF NOS IN SPINAL CORD IN RATS MODEL OF NEUROPATHIC PAIN

Effects of minocycline and TrkB/Fc on spinal brain-derived neurotrophic factor expression during development of neuropathic pain in rats

Effect of Intrathecal Glial Cell Line-Derived Neurotrophic Factor on P38mapk Protein Expression in Spinal Dorsal Horn in a Rat Model of Neuropathic Pain

Brain-derived neurotrophic factor contributes to spinal long-term potentiation and mechanical hypersensitivity by activation of spinal microglia in rat.

Expression of glial cell line-derived neurotrophic factor in dorsal root ganglion in rats with chronic neuropathic pain

Temporal Changes of Spinal Transcriptomic Profiles in Mice With Spinal Nerve Ligation.

Effects of Subcutaneous Transfection of Human Beta-Nerve Growth Factor Gene on Expression of Substance P in Dorsal Root Ganglion in a Rat Model of Diabetic Neuropathic Pain